首页> 外文期刊>Revue de Laryngologie Otologie Rhinologie >Veine cephalique et chambre a catheter implantable. Technique et suivi a long terme
【24h】

Veine cephalique et chambre a catheter implantable. Technique et suivi a long terme

机译:头静脉和可植入导管腔。技术和长期监控

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: to evaluate 1) the advantages and drawbacks of the cephalic vein access for totally implantable venous access devices (TIVAD) ; 2) the complications of such devices at long-term follow-up. Patients and methods: a retrospective study of a series of 107 cephalic vein accesses attempted on 105 patients from January 1997 to December 2001, in our department. They were 87 men and 18 women, aged from 25 to 85 years (mean: 59). The authors evaluated in each case the surgical technique, the peroprative incidents, the side of surgery, and the short-term and long-term complications. The total follow-up reached 41 284 days. Results: the cephalic vein access attempt failed in 12 cases (11%). These failures were due to intravenous blockade of the flexible catheter or to misroutine of the catheter in 5 cases and to a too thin vein in 7 cases. There was no statistically significant difference between the right and left sides. There was no technique-related complication. There were 18 postoperative complications (19%) out of the 95 devices that were implanted: 6 venous thrombosis, 7 infections, 4 catheter disconnections including 3 intra-cardiac migrations, 1 catheter occlusion. In 12 of these cases, the whole device had to be withdrawn. In the whole series, the devices were withdrawn at mean of 435 days after implantation. Conclusion: the use of a TIVAD is necessary when a chemotherapy must be delivered for treatment of a cancer. Cephalic vein access appears to be easy, quick and relatively safe. Postoperatively, serious complications can be encountered like with any type of TIVAD. These complications must be well-know if one wants to manage them well.
机译:目的:评估1)完全植入式静脉通路装置(TIVAD)的头静脉通路的优缺点; 2)长期随访中此类器械的并发症。患者和方法:回顾性研究了我科自1997年1月至2001年12月对105例患者进行的一系列107例头颅静脉通路的尝试。他们是87名男性和18名女性,年龄从25岁到85岁(平均59岁)。作者评估了每种情况下的手术技术,围手术期事件,手术方面以及短期和长期并发症。总随访时间为41 284天。结果:12例(11%)的头静脉接入失败。这些失败是由于5例挠性导管的静脉阻塞或导管程序不当以及7例由于静脉太细造成的。左右两侧之间没有统计学上的显着差异。没有技术相关的并发症。在植入的95台器械中,有18例术后并发症(19%):6例静脉血栓形成,7例感染,4例导管断开,包括3例心脏内迁移,1例导管阻塞。在其中12种情况下,必须撤回整个设备。在整个系列中,植入后平均435天撤回器械。结论:当必须进行化学疗法治疗癌症时,必须使用TIVAD。头静脉进入似乎很容易,快速且相对安全。术后,像任何类型的TIVAD一样,都会遇到严重的并发症。如果要很好地处理这些并发症,必须知道这些并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号